Sunday, 19 February 2017
Last updated 1 day ago
Nov 28 2007 | 12:25pm ET
Investment firm Carl Marks & Co. has partnered with hedge fund manager BlueStar Capital Management to launch the BlueStar CM Life Sciences Focus Fund. The partnership also gives Carl Marks a stake in BlueStar Capital Management, which invests in healthcare hedge funds.
The new Focus Fund holds a long/short portfolio that includes public healthcare equities in both managed accounts and limited partnerships.
"We feel the healthcare market provides attractive and solid investment opportunities," said Mark Claster, president of Carl Marks.
Jonathan Lach of BlueStar Capital said, "The Focus Fund is invested in the best ideas of some of the best investors in public healthcare equities, a sector that is rich with investment opportunity."
Andrew Boas, a principal at Carl Marks, will join BlueStar Capital's advisory board.